Page last updated: 2024-08-16

propidium and bruceantin

propidium has been researched along with bruceantin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christov, K; Cuendet, M; Deng, Y; Hedayat, S; Helson, L; Lantvit, DD; McChesney, JD; Pezzuto, JM	1

Other Studies

1 other study(ies) available for propidium and bruceantin

Article	Year
Multiple myeloma regression mediated by bruceantin. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-01, Volume: 10, Issue:3 Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carbocyanines; Carrier Proteins; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspases; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Fluorescent Dyes; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Membrane Potentials; Mice; Mice, SCID; Mitochondria; Models, Chemical; Multiple Myeloma; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; Propidium; Proto-Oncogene Proteins c-myc; Quassins	2004

Article

Year

Multiple myeloma regression mediated by bruceantin.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-01, Volume: 10, Issue:3

Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carbocyanines; Carrier Proteins; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspases; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Fluorescent Dyes; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Membrane Potentials; Mice; Mice, SCID; Mitochondria; Models, Chemical; Multiple Myeloma; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; Propidium; Proto-Oncogene Proteins c-myc; Quassins

2004